| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
BRIEF REPORT |
Department of Biochemistry (S.A.P.C.), Fremantle Hospital, Fremantle, Western Australia; and School of Medicine and Pharmacology (W.A.D., T.M.E.D.), University of Western Australia, Fremantle Hospital, Fremantle, Western Australia 6959, Australia
Address all correspondence and requests for reprints to: Dr. S. A. P. Chubb, Department of Biochemistry, Fremantle Hospital, P.O. Box 480, Fremantle, Western Australia 6959, Australia. E-mail: paul.chubb{at}health.wa.gov.au.
Context: Recent observations in healthy subjects showed that insulin resistance modifies the relationship between serum cholesterol and thyroid function.
Objective: The aim of the study was to determine whether insulin sensitivity modifies the association between thyroid dysfunction and lipid parameters in diabetic patients.
Design: This is a cross-sectional study.
Setting: This is a community-based observational study.
Patients: One hundred seventeen females with type 2 diabetes who were not taking oral hypoglycemic therapy, insulin, or lipid-lowering therapy participated in the study.
Intervention: Serum TSH, insulin, total and high-density lipoprotein cholesterol, and triglycerides were measured.
Main Outcome Measures: Age-adjusted multiple linear regression analysis of serum lipid concentrations and derived parameters, as functions of serum TSH and homeostasis model assessment-derived insulin sensitivity (HOMA-S), were measured.
Results: The relationship among serum lipid concentrations, serum TSH, and HOMA-S was significantly modified by an interaction term ln(TSH)*ln(HOMA-S). In three-dimensional graphs, there were strong positive associations between TSH and lipid parameters with adverse cardiac risks at low insulin sensitivity that were absent at higher insulin sensitivity. The effect was strongest for lipid risk factors associated with insulin resistance.
Conclusions: The interaction between thyroid function and insulin sensitivity is an important contributor to diabetic dyslipidemia and may justify T4 replacement in some patients.
This article has been cited by other articles:
![]() |
A. Mueller, C. Schofl, R. Dittrich, S. Cupisti, P.G. Oppelt, R.L. Schild, M.W. Beckmann, and L. Haberle Thyroid-stimulating hormone is associated with insulin resistance independently of body mass index and age in women with polycystic ovary syndrome Hum. Reprod., November 1, 2009; 24(11): 2924 - 2930. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Roos, S. J. L. Bakker, T. P. Links, R. O. B. Gans, and B. H. R. Wolffenbuttel Thyroid Function Is Associated with Components of the Metabolic Syndrome in Euthyroid Subjects J. Clin. Endocrinol. Metab., February 1, 2007; 92(2): 491 - 496. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-M. Fernandez-Real, A. Lopez-Bermejo, A. Castro, R. Casamitjana, and W. Ricart Thyroid Function Is Intrinsically Linked to Insulin Sensitivity and Endothelium-Dependent Vasodilation in Healthy Euthyroid Subjects J. Clin. Endocrinol. Metab., September 1, 2006; 91(9): 3337 - 3343. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |